Fluidigm's saliva based RT-PCR kit receives approval in India

Fluidigm’s saliva based RT-PCR kit receives approval in India
24 December 2020 | News
Source credit: Fluidigm
With the increased reliance on saliva based testing, US based Fluidigm has revealed that its Advanta Dx SARS-COV-2 RT-PCR kit, which is a saliva based diagnostic test has been authorized for use in India.
This kit facilitates SARS-CoV-2 detection from saliva samples easing the sample collection process & eliminating the need for Viral RNA extraction process. The kit is compatible with Fluidigm’s high-throughput Biomark HD platform. Fluidigm claims that with certain configurations, the Biomark HD system can run a maximum of 6000 samples and controls per day.

Related Keywords

India , New Delhi , Delhi , Premas Lifesciences , Praveen Gupta , Chris Linthwaite , Premas Lifesciences Pvt Ltd , Fluidigm , Fda Eua , Rt Pcr , Saliva Based , Advanta Dx , Sars Cov 2 , Biomark Hd , இந்தியா , புதியது டெல்ஹி , டெல்ஹி , ப்ரவீன் குப்தா , ஃப்ட ஏஉ , ர்ட் ப்க்ர் , உமிழ்நீர் அடிப்படையிலானது ,